Symposium: Onset of action for the relief of allergic rhinitis symptoms with second-generation antihistamines

Allergy and Asthma Proceedings

Volumn 25, Issue 2, 2004, Pages 81-83

  Greisner III, William A ^a,b  

^a Allerg Asthma Assoc the Bluegrass   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; DESLORATADINE; FEXOFENADINE; LORATADINE; DRUG DERIVATIVE; HISTAMINE H1 RECEPTOR ANTAGONIST; TERFENADINE;

ALLERGIC RHINITIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG MECHANISM; HUMAN; MEDICAL LITERATURE; POLLEN; SYMPTOMATOLOGY; HAY FEVER; REVIEW; TIME;

CETIRIZINE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LORATADINE; RHINITIS, ALLERGIC, SEASONAL; TERFENADINE; TIME FACTORS;

EID: 4043154960     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Meltzer EO, Weiler JM, and Widlitz MD. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. J Allergy Clin Immunol 97:617-626, 1996.
2. Davies HJ. Exposure of hay fever subjects to an indoor environmental grass pollen challenge system. Clin Allergy 15:419-427, 1985.
3. Horak F, and Jager S. The Vienna challenge chamber (VCC) - A new method for allergen exposition tests. Wien Klin Wochenschr 99:509-510, 1987.
4. Day JH, Briscoe MP, Clark RH, et al. Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis. Ann Allergy Asthma Immunol 79:163-172, 1997.
5. Day JH, Briscoe MP, Welsh A, et al. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit. Ann Allergy Asthma Immunol 79:533-540, 1997.
6. Day JH, Briscoe M, and Widlitz MD. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: Effects after controlled ragweed pollen challenge in an environmental exposure unit. J Allergy Clin Immunol 101:638-645, 1998.
7. Day JH, Briscoe M, Rafeiro E, et al. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: Confirmation of a test system. Ann Allergy Asthma Immunol 87:474-481, 2001.
8. Simons FE, McMillan Janice L, and Simons KJ. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: Suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 86:540-547, 1990.
9. Grant JA, Danielson L, Rijoux J-P, et al. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: Suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects. Allergy 54:700-707, 1999.